IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection
Alyse Frisbee(University of Virginia Health System), William A. Petri(University of Virginia)
Cited by 137
Related Papers
IL-13 is a driver of COVID-19 severity
|JCI Insight|2021|159
IL-13 is a driver of COVID-19 severity
|medRxiv|2020|73
IL-13 protects from Clostridioides difficile colitis
|Anaerobe|2024|7
The IL-33-ILC2 pathway protects from amebic colitis
|bioRxiv (Cold Spring Harbor Laboratory)|2021|1